Low GAS5 Levels as a Predictor of Poor Survival in Patients with Lower-Grade Gliomas.

Taken together, these results demonstrate that GAS5 expression is associated with OS in LGG patients and that its underlying roles involve the regulation of ribosomal biogenesis and translation initiation, which may aid in identifying a new target for the treatment of LGG.